Fragment based drug discovery using fluorescence correlation: spectroscopy techniques: challenges and solutions.

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Structural Biology

Background:

• Identifying novel starting points for drug discovery is crucial for medicinal chemistry programs.
• High-concentration screening of fragment libraries in biochemical assays is an effective strategy.
• Sensitive detection methods are essential for identifying weakly active fragment molecules.

Purpose of the Study:

• To demonstrate the successful application of high-concentration fragment screening using advanced detection techniques.
• To validate the reproducibility and sensitivity of single-molecule Fluorescence Correlation Spectroscopy (FCS+plus).
• To determine the binding modes of identified active fragments to target proteins.

Main Methods:

• High-concentration screening of fragment libraries using biochemical assays.
• Utilizing a portfolio of single-molecule Fluorescence Correlation Spectroscopy (FCS+plus) techniques.
• X-ray crystallography for determining fragment-protein binding modes.
• Review of additional biophysical detection methods for fragment binding studies.

Main Results:

• Successful identification of weakly active fragment molecules through high-concentration screening.
• Demonstrated high reproducibility and sensitivity using FCS+plus techniques.
• Determined the binding modes of active fragments via X-ray crystallography.

Conclusions:

• High-concentration fragment screening is a viable strategy for identifying novel drug leads.
• Advanced biophysical techniques like FCS+plus enhance the sensitivity and reproducibility of fragment screening.
• Structural information from X-ray crystallography aids in understanding fragment-protein interactions for drug design.